Morgan Stanley
NPTN

Morgan Stanley’s NEOPHOTONICS CORP NPTN Stock Holding History

Morgan Stanley’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-991,236
Closed -$15.6M – 8185
2022
Q2 		$15.6M Buy
991,236
+392,101
+65% +$5.99M ﹤0.01% 2562
2022
Q1 		$9.11M Sell
599,135
-2,758
-0.5% -$42K ﹤0.01% 3008
2021
Q4 		$9.25M Buy
601,893
+589,383
+4,711% +$7.75M ﹤0.01% 3028
2021
Q3 		$109K Sell
12,510
-152,242
-92% -$1.39M ﹤0.01% 6319
2021
Q2 		$1.68M Buy
164,752
+151,468
+1,140% +$1.6M ﹤0.01% 4761
2021
Q1 		$159K Sell
13,284
-28,154
-68% -$319K ﹤0.01% 5786
2020
Q4 		$376K Buy
41,438
+34,064
+462% +$264K ﹤0.01% 5248
2020
Q3 		$45K Sell
7,374
-15,104
-67% -$115K ﹤0.01% 5756
2020
Q2 		$200K Buy
22,478
+5,149
+30% +$44.4K ﹤0.01% 5077
2020
Q1 		$126K Sell
17,329
-247,769
-93% -$1.84M ﹤0.01% 5087
2019
Q4 		$2.34M Buy
265,098
+70,749
+36% +$529K ﹤0.01% 3917
2019
Q3 		$1.18M Sell
194,349
-93,659
-33% -$526K ﹤0.01% 4192
2019
Q2 		$1.2M Buy
288,008
+246,577
+595% +$1.3M ﹤0.01% 4127
2019
Q1 		$261K Sell
41,431
-53,581
-56% -$375K ﹤0.01% 4918
2018
Q4 		$615K Sell
95,012
-346,464
-78% -$2.65M ﹤0.01% 4651
2018
Q3 		$3.67M Buy
441,476
+360,836
+447% +$2.74M ﹤0.01% 3506
2018
Q2 		$502K Sell
80,640
-145,144
-64% -$923K ﹤0.01% 5096
2018
Q1 		$1.55M Buy
225,784
+81,774
+57% +$519K ﹤0.01% 4229
2017
Q4 		$948K Sell
144,010
-109,860
-43% -$671K ﹤0.01% 4575
2017
Q3 		$1.41M Buy
253,870
+134,743
+113% +$909K ﹤0.01% 4183
2017
Q2 		$920K Buy
119,127
+27,601
+30% +$233K ﹤0.01% 4427
2017
Q1 		$824K Sell
91,526
-113,227
-55% -$1.18M ﹤0.01% 4520
2016
Q4 		$2.21M Buy
204,753
+65,215
+47% +$870K ﹤0.01% 3839
2016
Q3 		$2.28M Buy
139,538
+81,696
+141% +$1.15M ﹤0.01% 3392
2016
Q2 		$552K Sell
57,842
-6,588
-10% -$71.7K ﹤0.01% 4371
2016
Q1 		$904K Buy
64,430
+38,414
+148% +$398K ﹤0.01% 4025
2015
Q4 		$282K Sell
26,016
-333,963
-93% -$3.02M ﹤0.01% 4897
2015
Q3 		$2.45M Buy
359,979
+143,999
+67% +$1.11M ﹤0.01% 3326
2015
Q2 		$1.97M Sell
215,980
-112,510
-34% -$853K ﹤0.01% 3639
2015
Q1 		$2.22M Buy
328,490
+324,331
+7,798% +$1.3M ﹤0.01% 3511
2014
Q4 		$14K Sell
4,159
-8
-0.2% -$26 ﹤0.01% 6144
2014
Q3 		$14K Sell
4,167
-5,798
-58% -$18.1K ﹤0.01% 6109
2014
Q2 		$42K Sell
9,965
-6,681
-40% -$35.4K ﹤0.01% 5823
2014
Q1 		$132K Buy
16,646
+1,214
+8% +$9.04K ﹤0.01% 5318
2013
Q4 		$109K Buy
15,432
+136
+0.9% +$907 ﹤0.01% 5320
2013
Q3 		$113K Sell
15,296
-63,239
-81% -$492K ﹤0.01% 5060
2013
Q2 		$682K Buy
+78,535
New +$505K ﹤0.01% 4030

Other funds holding NPTN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Morgan Stanley's NPTN Position: Q3 2022 in Review

Morgan Stanley sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 991,236 shares — an estimated $15.6M sold.

Morgan Stanley first reported a position in NPTN in Q2 2013 and held it in 37 quarters. The position peaked at $15.6M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Morgan Stanley reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Morgan Stanley sold 991,236 NEOPHOTONICS CORP shares in Q3 2022, an estimated $15.6M.
  • Morgan Stanley first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 37 quarters.
  • Morgan Stanley's NEOPHOTONICS CORP position peaked at $15.6M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.